Aigen Investment Management, LP Alaunos Therapeutics, Inc. Transaction History

Aigen Investment Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$2.82 - $5.6 $48,695 - $96,700	-17,268 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$2.09 - $3.09 $222,562 - $329,051	-106,489 Reduced 86.05%	17,268 $44,000
Q3 2020 Nov 06, 2020	SELL	$2.39 - $3.43 $135,130 - $193,932	-56,540 Reduced 31.36%	123,757 $312,000
Q2 2020 Aug 10, 2020	BUY	$2.2 - $3.71 $396,653 - $668,901	180,297 New	180,297 $591,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $424M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.